Patient Guide: A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 74 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05283720
Status: 🟢 Enrolling Now
Condition: Non-Hodgkin Lymphoma
Phase: PHASE2

Where You Can Participate

This study is available at 74 locations across the country.

Top locations include:
  • • Tucson, Arizona
  • • New Haven, Connecticut
  • • Newark, Delaware
  • • And 71 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma - Join Clinical Trial NCTNCT05283720

How to Join This Clinical Trial - NCTNCT05283720

Learn how to participate in this PHASE2 trial studying an investigational therapy for Non-Hodgkin Lymphoma. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Non-Hodgkin Lymphoma. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Non-Hodgkin Lymphoma
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT05283720 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 74 locations. Find a study site near you:

Clinical Research Site

Tucson, Arizona 85719 - United States

Status: RECRUITING

Clinical Research Site

New Haven, Connecticut 06510 - United States

Status: RECRUITING

Clinical Research Site

Newark, Delaware 19713 - United States

Status: RECRUITING

Clinical Research Site

Tampa, Florida 33606 - United States

Status: RECRUITING

Clinical Research Site

Atlanta, Georgia 30322 - United States

Status: RECRUITING

Clinical Research Site

Baltimore, Maryland 21201 - United States

Status: RECRUITING

Clinical Research Site

Kansas City, Missouri 64114-4859 - United States

Status: COMPLETED

Clinical Research Site

Lake Success, New York 11042 - United States

Status: RECRUITING

Clinical Research Site

New York, New York 10029 - United States

Status: RECRUITING

Clinical Research Site

Charlotte, North Carolina 28204 - United States

Status: RECRUITING

And 64 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Non-Hodgkin Lymphoma:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships